stock listing SomaLogic to List on Nasdaq Following SPAC Merger, Raises $630M Through the transaction, which values SomaLogic at roughly $1.2 billion, the company received gross cash proceeds of approximately $630 million. SomaLogic Reports Preliminary Q2 Revenues up 176 Percent The company projected Q2 revenues of $19.7 million and said the SEC had declared effective its proposed business combination with SPAC CM Life Sciences II. Protein Sequencing Firm Quantum-Si to Go Public Through Special Purpose Acquisition Company Merger The proteomics firm is expected to receive $514 million in proceeds through the deal, including a $425 million private investment in public equity (PIPE) transaction. Nautilus Biotechnology to Go Public on Nasdaq Through Merger With Special Purpose Acquisition Firm The proteomics firm is expected to receive $350 million in proceeds through the deal, including a $200 million private investment in public equity (PIPE) transaction. Bionano Genomics Stock Soars on User Presentations, Public Stock Offering, Renewed Nasdaq Compliance Buoyed by a string of positive news, the San Diego firm's stock was up 22 percent in Friday afternoon trading and 80 percent from last week. Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements Apr 27, 2020 Biocept Files $100M Shelf Registration May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Mar 22, 2018 Bio-Rad Receives Notice From NYSE for Late Filing of Annual Report Jan 9, 2018 Genetic Technologies Regains Compliance With Nasdaq Listing Rules Oct 18, 2017 Novacyt Raises €9.7M Aug 31, 2017 Interpace Regains Compliance With Nasdaq Listing Rule Jul 14, 2017 BGI Genomics Raises RMB 547M in IPO Jun 22, 2017 OpGen Warned by Nasdaq of Non-Compliance Apr 13, 2017 Interpace Diagnostics Regains Nasdaq Compliance Feb 21, 2017 Transgenomic Delisted from Nasdaq Jan 25, 2017 Biocept Regains Nasdaq Compliance Jan 17, 2017 Interpace Dx Regains Compliance With Nasdaq Listing Requirement Dec 15, 2016 WaferGen Regains Compliance With Nasdaq Listing Requirements Nov 28, 2016 Signal Genetics Regains Compliance With Nasdaq Listing Requirement Jul 11, 2016 Interpace Dx Gets Additional Time to Comply With Nasdaq Listing Requirements Jan 19, 2016 Toronto Stock Exchange Reviewing GeneNews' Eligibility for Continued Listing Feb 6, 2015 VolitionRx Begins Trading on NYSE MKT, Prices Public Offering at $3.75 per Share Feb 4, 2015 Genetic Technologies Regains Compliance with Nasdaq Listing Requirement, Works to Meet Another Requirement Dec 6, 2012 NeoGenomics Moves to Nasdaq Capital Market Load More Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.